(Q37734445)

22 August 2017

Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers (English)

1 reference

22 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

C J L la Porte

1

1 reference

22 August 2017

E P H Colbers

2

1 reference

22 August 2017

R Bertz

3

1 reference

22 August 2017

D S Voncken

4

1 reference

22 August 2017

K Wikstrom

5

1 reference

22 August 2017

M J Boeree

6

1 reference

22 August 2017

P P Koopmans

7

1 reference

22 August 2017

Y A Hekster

8

1 reference

22 August 2017

D M Burger

9

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Antimicrobial Agents and Chemotherapy

22 August 2017

1 reference

22 August 2017

48

1 reference

22 August 2017

5

1 reference

22 August 2017

1553-1560

1 reference

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Interactions among drugs for HIV and opportunistic infections

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Pharmacokinetic factors in the modern drug treatment of tuberculosis.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

The double burden of HIV infection and tuberculosis in sub-Saharan Africa

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

The treatment of tuberculosis in HIV-infected persons.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400571

Ritonavir enables combined therapy with rifampin and saquinavir

1 September 2018

1 reference

12 December 2020

Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts

1 reference

12 December 2020

10.1128/AAC.48.5.1553-1560.2004

Identifiers

DOI

1 reference

22 August 2017

1 reference

22 August 2017

PubMed publication ID

15105105

1 reference